| 000 -LEADER |
|---|
| fixed length control field |
02969cam a22003854a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20150712005523.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
070809s2008 nyua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0824758099 (hb : alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Language of cataloging |
eng |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
W1 |
| Item number |
AP |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 744 |
| Item number |
P923 2008 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
22 |
| 084 ## - OTHER CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Item number |
AP |
| 001 - CONTROL NUMBER |
|---|
| control field |
0000066036 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
0000 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Adeyeye ,Moji C. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Preformulation solid dosage form development |
| Medium |
[[Book] /] |
| Statement of responsibility, etc. |
Moji C. Adeyeye, Harry G. Brittain. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
New York : |
| Name of publisher, distributor, etc. |
Informa Healthcare USA, |
| Date of publication, distribution, etc. |
2008. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
viii, 596 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Drugs and the pharmaceutical sciences ; |
| Volume/sequential designation |
178 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Accelerating the course of preliminary-preformulation through prediction of molecular physical properties and integrated analytical data management / Robert S. DeWitte, Michel Hachey, and Harry G. Brittain -- Prediction of crystallographic characteristics / Steve Spanton -- Salt selection for pharmaceutical compounds / Sherif I. Badawy, Miriam K. Franchini, and Munir A. Hussain -- Intelligent preformulation design and predictions using artificial neural networks / Nkere K. Ebube -- Developing a profile of the active pharmaceutical ingredient / Harry G. Brittain -- Particle morphology and characterization in preformulation / Alan Rawle -- Preparation and identification of polymorphs and solvatomorphs / Harry G. Brittain -- X-ray diffraction methods for the characterization of solid pharmaceutical materials / Jean Blachere and Harry G. Brittain -- Spectroscopic methods for the characterization of drug substances / Harry G. Brittain -- Thermal analysis and calorimetric methods for the characterization of new crystal forms / Dennette Murphy Shelley Rabel -- Solubility methods for the characterization of new crystal forms / Harry G. Brittain -- Overview of the solid dosage form preformulation program / Harry G. Brittain -- Drug-excipient interactions appropriate to solid dosage forms / Moji Christianah Adeyeye -- Methods for the determination of the physical and chemical stability of a new solid dosage form / Harry G. Brittain -- Dissolution testing / Chuck Collins and George Wong -- Structure, content, and format of the preformulation report / Ram N. Gidwani -- Significance of drug substance physicochemical properties in regulatory quality by design / Sau Lawrence Lee, Andre S. Raw, and Lawrence Yu. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
All age. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Solid dosage forms. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug development. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical chemistry. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Chemistry, Pharmaceutical. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Dosage Forms. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical Preparations |
| General subdivision |
chemical synthesis. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Brittain, H. G. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Adeyeye, Moji C. |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0740/2007033181-d.html |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
